503A U.S. Compounding Pharmacies Market Revenue 2024 to 2034
503A U.S. Compounding Pharmacies Market Revenue 2024 to 2034
The 503A U.S. compounding pharmacies market is projected to reach USD 8.08 billion by 2034, growing from USD 4.74 billion in 2025, at a CAGR of 6.11% during the forecast period from 2025 to 2034, increasing demand for personalized, convenient and accessible care.
Report ID: 10095
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 4.47 Bn
Forecast Year,
USD USD 8.08 Bn
CAGR, 2025 -
6.11%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
503A U.S. Compounding Pharmacies Market Size Analysis
503A U.S. Compounding Pharmacies Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 1117.50 | 1196.42 | 1280.74 | 1370.83 | 1467.08 | 1569.89 | 1679.70 | 1796.99 | 1922.24 | 2056.00 | 2198.83 |
| Liquid Preparations | 894.00 | 931.60 | 970.56 | 1010.92 | 1052.71 | 1095.96 | 1140.69 | 1186.94 | 1234.73 | 1284.07 | 1335.00 |
| Topical | 670.50 | 723.53 | 780.45 | 841.55 | 907.13 | 977.48 | 1052.95 | 1133.89 | 1220.70 | 1313.76 | 1413.53 |
| Rectal | 447.00 | 458.71 | 470.27 | 481.64 | 492.76 | 503.55 | 513.94 | 523.85 | 533.18 | 541.83 | 549.71 |
| Ophthalmic | 447.00 | 487.08 | 530.31 | 576.91 | 627.15 | 681.27 | 739.57 | 802.35 | 869.92 | 942.64 | 1020.88 |
| Nasal | 447.00 | 458.71 | 470.27 | 481.64 | 492.76 | 503.55 | 513.94 | 523.85 | 533.18 | 541.83 | 549.71 |
| Otic | 447.00 | 487.08 | 530.31 | 576.91 | 627.15 | 681.27 | 739.57 | 802.35 | 869.92 | 942.64 | 1020.88 |
503A U.S. Compounding Pharmacies Market Size By Sterility 2024 to 2034 (USD )
| Sterility | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterile | 2682.00 | 2860.10 | 3049.95 | 3252.32 | 3468.04 | 3697.98 | 3943.06 | 4204.30 | 4482.73 | 4779.49 | 5095.79 |
| Non-Sterile | 1788.00 | 1883.02 | 1982.97 | 2088.11 | 2198.69 | 2314.99 | 2437.30 | 2565.91 | 2701.13 | 2843.30 | 2992.76 |
503A U.S. Compounding Pharmacies Market Size By Therapeutic Area 2024 to 2034 (USD )
| Therapeutic Area | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hormone replacement | 1117.50 | 1200.01 | 1288.43 | 1383.17 | 1484.68 | 1593.44 | 1709.94 | 1834.73 | 1968.38 | 2111.51 | 2264.79 |
| Pain management | 894.00 | 934.39 | 976.39 | 1020.02 | 1065.35 | 1112.40 | 1161.23 | 1211.87 | 1264.36 | 1318.74 | 1375.05 |
| Dermatology | 670.50 | 725.70 | 785.14 | 849.13 | 918.01 | 992.14 | 1071.90 | 1157.70 | 1249.99 | 1349.24 | 1455.94 |
| Pediatrics | 670.50 | 697.24 | 724.74 | 753.00 | 782.01 | 811.75 | 842.21 | 873.36 | 905.17 | 937.60 | 970.63 |
| Urology | 447.00 | 488.54 | 533.49 | 582.11 | 634.67 | 691.49 | 752.88 | 819.19 | 890.80 | 968.10 | 1051.51 |
| Others | 670.50 | 697.24 | 724.74 | 753.00 | 782.01 | 811.75 | 842.21 | 873.36 | 905.17 | 937.60 | 970.63 |
503A U.S. Compounding Pharmacies Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals and Clinics | 1788.00 | 1905.76 | 2031.18 | 2164.75 | 2307.01 | 2458.51 | 2619.83 | 2791.63 | 2974.57 | 3169.36 | 3376.77 |
| Specialty Clinics | 1564.50 | 1640.94 | 1721.00 | 1804.84 | 1892.64 | 1984.58 | 2080.83 | 2181.58 | 2287.05 | 2397.43 | 2512.95 |
| Other | 1117.50 | 1196.42 | 1280.74 | 1370.83 | 1467.08 | 1569.89 | 1679.70 | 1796.99 | 1922.24 | 2056.00 | 2198.83 |
503A U.S. Compounding Pharmacies Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
